Danone SA
XMUN:BSN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
Danone SA
XMUN:BSN
|
FR |
|
B
|
Bristol-Myers Squibb Co
SWB:BRM
|
US |
|
R
|
Roper Technologies Inc
NASDAQ:ROP
|
US |
|
C
|
Cadence Design Systems Inc
XMUN:CDS
|
US |
|
Coca Cola HBC AG
F:CCKC
|
CH |
|
E
|
EEI Corp
XPHS:EEI
|
PH |
|
R
|
Reckitt Benckiser Group PLC
XMUN:3RB
|
UK |
|
D
|
Dynex Capital Inc
F:DYT1
|
US |
|
A
|
American Electric Power Company Inc
XMUN:AEP
|
US |
Wall St Price Targets
BSN Price Targets Summary
Danone SA
According to Wall Street analysts, the average 1-year price target for BSN is 83.36 EUR with a low forecast of 66.4 EUR and a high forecast of 100.88 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BSN's stock price target?
Price Target
83.36
EUR
According to Wall Street analysts, the average 1-year price target for BSN is 83.36 EUR with a low forecast of 66.4 EUR and a high forecast of 100.88 EUR.
What is the Revenue forecast for Danone SA?
Projected CAGR
3%
Over the last 14 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 8 years is 3%.
What is the Operating Income forecast for Danone SA?
Projected CAGR
4%
Over the last 14 years, the compound annual growth rate for Operating Income has been 2%. The projected CAGR for the next 8 years is 4%.
What is the Net Income forecast for Danone SA?
Projected CAGR
15%
Over the last 14 years, the compound annual growth rate for Net Income has been 1%. The projected CAGR for the next 5 years is 15%.
